<DOC>
	<DOCNO>NCT01699126</DOCNO>
	<brief_summary>study Hypothesis : We hypothesize CPAP could effectively improve endothelial dysfunction anti-inflammatory effect patient OSA , compare effect statin .</brief_summary>
	<brief_title>The Endothelium Dysfunction Patients Obstructive Sleep Apnea Syndrome</brief_title>
	<detailed_description>Obstructive sleep apnea prevalent disorder affect 2-4 % adult general population . Cardiovascular Neurocognitive complication common severe consequence note patient OSA . Endothelial dysfunction early pathologic change vascular wall precede clinical cardiovascular event . Endothelial dysfunction deficit vascular relaxation induce development hypertension . Endothelial dysfunction predict occurrence ischemic heart disease cardiovascular event stroke . The development endothelial dysfunction significantly remark early sign development cardiovascular disease . Inflammation trigger oxygen radical vascular system major pathogenesis endothelial dysfunction . Intermittent hypoxia patient OSA repeat apnea night increase oxygen radical therefore trigger cascade inflammation process . The inflammatory process could mediate activation transcription factor NF-KB , AP-1 pathway HIF-1 cascade . Inflammatory cytokine HsCRP induct activation NF-KB AP-1 induce interaction monocytes lymphocytes injury endothelium vascular wall . TGF-B secrete lymphocyte create remodel fibroblast result thicken vascular wall . Another pathway VEGF , endothelin 1 , protein modulate HIF-1 also propose directly injure endothelium cause follow cardiovascular event . CPAP treatment OSA show lower severity blood pressure cardiovascular event report . Although effect blood pressure lower still controversial , Most report actually show marginal effect reduce BP 2 mmHg CPAP . There still part OSA patient hypertension respond CPAP treatment.Besides effect CPAP treatment , compliance CPAP still major concern treatment OSA . 60 % patient report continue use CPAP well-supported sleep center USA . Even CPAP cover reimbursement USA , low compliance CPAP impede treatment cardiovascular complication OSA . To improve control cardiovascular consequence OSA , convenient well-tolerated intervention mandatory . Statin , powerful lipid-lowering medication , find significant anti-inflammatory effect several report . Statin even suggest population normal cholesterol prevent development cardiovascular event . Statins exert cholesterol-independent , anti-inflammatory immunomodulatory effect . Pleiotropic effect typically mediate HMG-CoA reductase inhibition , dose dependent occur rapidly initiation statin treatment . In order evaluate explore safe convenient method control cardiovascular complication OSA , conduct study .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>1.OSA AHI &gt; 30 2.Male patient hypertension 3.LDL 130 mg/dL without lipidlowering drug therapy recent 6 month 4.Signed inform consent cooperative 1.Noncooperative 2.Ca n't sign inform consent . 3.Had proven major cardiovascular complication AMI , CVA . 4.Major chronic disorder inflammatory disorder : DM , ESRD , COPD rheumatoid arthritis . 5.Under antiinflammatory medication : aspirin , NSAID , steroid , theophylline etc . 6.Acute chronic infection 1 week blood draw period discard 7.Study medication discontinue among subject develop myopathy ( CK ≥10 time ULN muscle ache weakness ) persistent elevation ALT ( ≥3 time ULN 2 consecutive test ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>CPAP</keyword>
	<keyword>Endothelium dysfunction</keyword>
	<keyword>Hypertension</keyword>
</DOC>